Share Price and Basic Stock Data
Last Updated: January 7, 2026, 5:56 pm
| PEG Ratio | -4.83 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
AVT Natural Products Ltd operates in the agricultural products sector, with a market capitalization of ₹997 Cr and a current share price of ₹65.6. The company reported total sales of ₹582 Cr for the fiscal year ending March 2023, reflecting a growth trend from ₹559 Cr in March 2022. However, revenue for the subsequent fiscal year (March 2024) declined to ₹517 Cr, before rebounding to ₹556 Cr in March 2025. Quarterly sales figures depict a fluctuating pattern, with Q2 FY2024 recording ₹135 Cr, which increased to ₹173 Cr by Q4 FY2024. This indicates potential seasonal variations in demand or operational challenges affecting sales consistency. The trailing twelve months (TTM) sales stood at ₹622 Cr, pointing to a recovery trend that may signal improved operational efficiencies or market conditions. The company’s ability to adapt to changing market dynamics will be pivotal in sustaining revenue growth in the coming quarters.
Profitability and Efficiency Metrics
AVT Natural Products Ltd reported a net profit of ₹61 Cr for the fiscal year ending March 2025, down from ₹77 Cr in the previous year. The operating profit margin (OPM) for the latest fiscal year was recorded at 13%, a decline from 21% in March 2023, highlighting potential pressure on profitability. The company maintained a return on equity (ROE) of 9.89% and a return on capital employed (ROCE) of 12.8%, which are moderately competitive when compared to industry averages. The interest coverage ratio stood at 9.11x, indicating strong ability to meet interest obligations. However, the cash conversion cycle (CCC) of 388 days poses a challenge, suggesting a longer time frame to convert investments into cash flows, which could affect liquidity. The declining trend in OPM and net profit indicates a need for cost management and operational efficiency improvements to enhance profitability.
Balance Sheet Strength and Financial Ratios
As of March 2025, AVT Natural Products Ltd reported total assets of ₹747 Cr, with liabilities amounting to ₹747 Cr, reflecting a balanced sheet. The company’s reserves stood at ₹508 Cr, showcasing a solid equity base. Borrowings increased to ₹100 Cr, which, while manageable, indicates reliance on debt financing that could affect financial stability if not managed prudently. The total debt to equity ratio was recorded at 0.21, suggesting a conservative leverage position compared to industry norms. The current ratio of 2.90 indicates robust liquidity, allowing the company to comfortably meet short-term obligations. However, the declining trend in return on assets (ROA), which fell to 6.45%, signals potential inefficiencies in asset utilization. This calls for a strategic review of asset management to elevate returns and overall financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of AVT Natural Products Ltd reveals a strong promoter holding of 75%, indicating significant insider confidence in the company’s prospects. The presence of foreign institutional investors (FIIs) at 0.07% and domestic institutional investors (DIIs) at 0.24% reflects limited institutional interest, which may affect the stock’s liquidity and market perception. The public shareholding stood at 24.72%, with a total of 50,306 shareholders reported. A slight increase in public shareholders over recent quarters suggests growing retail interest, which can be positive for market sentiment. However, the low institutional ownership might be a concern for potential investors seeking stability and credibility. The company needs to enhance investor relations and communicate its growth strategy effectively to attract more institutional investment, thereby improving overall market confidence.
Outlook, Risks, and Final Insight
The outlook for AVT Natural Products Ltd hinges on its ability to improve profitability metrics and operational efficiencies. While the recovery in sales is promising, the declining profit margins and high cash conversion cycle present significant risks. The company’s financial health is supported by strong asset management and a healthy liquidity position, but increasing borrowings could pose future risks if not managed carefully. The reliance on promoter ownership suggests confidence, yet the low institutional investment could limit growth potential. To navigate these challenges, the company must focus on cost optimization, enhancing operational efficiencies, and potentially diversifying its investor base. If it can successfully implement these strategies, AVT Natural Products Ltd may capitalize on market opportunities, thereby positioning itself for sustainable growth in the agricultural products sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 3,141 Cr. | 171 | 186/58.6 | 59.3 | 23.5 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 129 Cr. | 162 | 179/105 | 165 | 0.00 % | 7.35 % | 8.07 % | 10.0 | |
| City Crops Agro Ltd | 30.7 Cr. | 18.8 | 28.8/17.0 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,346 Cr. | 270 | 417/242 | 14.3 | 153 | 0.93 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 460 Cr. | 14.0 | 18.5/11.5 | 17.6 | 6.86 | 0.07 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,781.40 Cr | 245.99 | 27.36 | 106.69 | 0.33% | 11.80% | 12.33% | 4.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 160 | 139 | 134 | 103 | 135 | 154 | 125 | 105 | 122 | 173 | 157 | 132 | 160 |
| Expenses | 126 | 112 | 110 | 92 | 119 | 118 | 109 | 97 | 114 | 143 | 132 | 116 | 145 |
| Operating Profit | 34 | 27 | 24 | 11 | 17 | 36 | 16 | 8 | 8 | 30 | 25 | 16 | 15 |
| OPM % | 21% | 19% | 18% | 11% | 12% | 23% | 13% | 8% | 7% | 17% | 16% | 12% | 9% |
| Other Income | 3 | -1 | -1 | 3 | 5 | -0 | 5 | 5 | 5 | 4 | 2 | 4 | 5 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | 2 |
| Depreciation | 3 | 4 | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 3 | 3 |
| Profit before tax | 33 | 20 | 18 | 10 | 16 | 30 | 15 | 8 | 8 | 28 | 20 | 15 | 16 |
| Tax % | 25% | 34% | 21% | 19% | 27% | 26% | 26% | 25% | 17% | 23% | 27% | 18% | 16% |
| Net Profit | 25 | 13 | 14 | 8 | 12 | 22 | 11 | 6 | 6 | 22 | 14 | 12 | 13 |
| EPS in Rs | 1.64 | 0.88 | 0.93 | 0.55 | 0.76 | 1.47 | 0.72 | 0.39 | 0.41 | 1.42 | 0.94 | 0.80 | 0.87 |
Last Updated: January 2, 2026, 9:01 am
Below is a detailed analysis of the quarterly data for AVT Natural Products Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 160.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Jun 2025) to 160.00 Cr., marking an increase of 28.00 Cr..
- For Expenses, as of Sep 2025, the value is 145.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 116.00 Cr. (Jun 2025) to 145.00 Cr., marking an increase of 29.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Jun 2025) to 9.00%, marking a decrease of 3.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Jun 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 18.00% (Jun 2025) to 16.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Jun 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.87. The value appears strong and on an upward trend. It has increased from 0.80 (Jun 2025) to 0.87, marking an increase of 0.07.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:36 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 290 | 261 | 274 | 311 | 328 | 339 | 396 | 485 | 559 | 582 | 517 | 556 | 622 |
| Expenses | 216 | 214 | 235 | 269 | 295 | 297 | 339 | 414 | 454 | 461 | 438 | 486 | 537 |
| Operating Profit | 74 | 48 | 39 | 42 | 33 | 42 | 57 | 71 | 106 | 121 | 79 | 70 | 85 |
| OPM % | 25% | 18% | 14% | 14% | 10% | 12% | 14% | 15% | 19% | 21% | 15% | 13% | 14% |
| Other Income | 1 | 2 | 1 | 5 | 13 | 4 | 7 | 8 | 10 | 2 | 13 | 16 | 15 |
| Interest | 2 | 4 | 1 | 2 | 3 | 5 | 6 | 4 | 5 | 5 | 7 | 9 | 10 |
| Depreciation | 5 | 6 | 6 | 7 | 7 | 11 | 14 | 15 | 14 | 13 | 14 | 14 | 13 |
| Profit before tax | 67 | 41 | 33 | 38 | 36 | 30 | 45 | 61 | 97 | 105 | 71 | 63 | 78 |
| Tax % | 37% | 35% | 35% | 36% | 32% | 30% | 24% | 25% | 25% | 26% | 25% | 24% | |
| Net Profit | 42 | 26 | 22 | 24 | 24 | 21 | 34 | 45 | 73 | 77 | 53 | 48 | 61 |
| EPS in Rs | 2.76 | 1.73 | 1.42 | 1.61 | 1.59 | 1.37 | 2.23 | 2.97 | 4.78 | 5.08 | 3.50 | 3.17 | 4.03 |
| Dividend Payout % | 27% | 29% | 28% | 25% | 25% | 29% | 27% | 24% | 21% | 20% | 23% | 25% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -38.10% | -15.38% | 9.09% | 0.00% | -12.50% | 61.90% | 32.35% | 62.22% | 5.48% | -31.17% | -9.43% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.71% | 24.48% | -9.09% | -12.50% | 74.40% | -29.55% | 29.87% | -56.74% | -36.65% | 21.73% |
AVT Natural Products Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | -13% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | -12% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 12:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:00 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 152 | 171 | 185 | 209 | 223 | 236 | 260 | 295 | 354 | 415 | 454 | 491 | 508 |
| Borrowings | 5 | 7 | 10 | 15 | 36 | 81 | 46 | 54 | 25 | 37 | 43 | 113 | 100 |
| Other Liabilities | 64 | 44 | 39 | 36 | 55 | 56 | 57 | 62 | 55 | 56 | 86 | 128 | 169 |
| Total Liabilities | 237 | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 524 | 598 | 747 | 792 |
| Fixed Assets | 51 | 53 | 58 | 57 | 56 | 98 | 99 | 89 | 82 | 78 | 82 | 72 | 63 |
| CWIP | 0 | 2 | 1 | 0 | 28 | 0 | 0 | 0 | 2 | 0 | 0 | 4 | 14 |
| Investments | 15 | 7 | 28 | 38 | 30 | 7 | 8 | 8 | 28 | 58 | 127 | 136 | 115 |
| Other Assets | 171 | 175 | 162 | 180 | 215 | 283 | 271 | 329 | 337 | 387 | 390 | 535 | 600 |
| Total Assets | 237 | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 524 | 598 | 747 | 792 |
Below is a detailed analysis of the balance sheet data for AVT Natural Products Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 508.00 Cr.. The value appears strong and on an upward trend. It has increased from 491.00 Cr. (Mar 2025) to 508.00 Cr., marking an increase of 17.00 Cr..
- For Borrowings, as of Sep 2025, the value is 100.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 113.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 169.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 128.00 Cr. (Mar 2025) to 169.00 Cr., marking an increase of 41.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 792.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 747.00 Cr. (Mar 2025) to 792.00 Cr., marking an increase of 45.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 9.00 Cr..
- For CWIP, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 10.00 Cr..
- For Investments, as of Sep 2025, the value is 115.00 Cr.. The value appears to be declining and may need further review. It has decreased from 136.00 Cr. (Mar 2025) to 115.00 Cr., marking a decrease of 21.00 Cr..
- For Other Assets, as of Sep 2025, the value is 600.00 Cr.. The value appears strong and on an upward trend. It has increased from 535.00 Cr. (Mar 2025) to 600.00 Cr., marking an increase of 65.00 Cr..
- For Total Assets, as of Sep 2025, the value is 792.00 Cr.. The value appears strong and on an upward trend. It has increased from 747.00 Cr. (Mar 2025) to 792.00 Cr., marking an increase of 45.00 Cr..
Notably, the Reserves (508.00 Cr.) exceed the Borrowings (100.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 69.00 | 41.00 | 29.00 | 27.00 | -3.00 | -39.00 | 11.00 | 17.00 | 81.00 | 84.00 | 36.00 | -43.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 58 | 69 | 65 | 71 | 88 | 69 | 77 | 67 | 76 | 78 | 103 |
| Inventory Days | 248 | 278 | 184 | 205 | 186 | 341 | 235 | 258 | 263 | 342 | 365 | 431 |
| Days Payable | 59 | 37 | 28 | 39 | 68 | 82 | 43 | 59 | 45 | 44 | 98 | 146 |
| Cash Conversion Cycle | 236 | 300 | 226 | 231 | 188 | 347 | 261 | 275 | 284 | 373 | 345 | 388 |
| Working Capital Days | 114 | 159 | 143 | 119 | 116 | 166 | 151 | 159 | 163 | 176 | 171 | 172 |
| ROCE % | 40% | 25% | 17% | 17% | 14% | 11% | 15% | 19% | 27% | 26% | 16% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| Diluted EPS (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| Cash EPS (Rs.) | 4.08 | 4.41 | 5.96 | 5.73 | 3.97 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 33.25 | 30.83 | 28.26 | 24.21 | 20.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 33.25 | 30.83 | 28.26 | 24.21 | 20.37 |
| Revenue From Operations / Share (Rs.) | 36.51 | 33.97 | 38.23 | 36.73 | 31.86 |
| PBDIT / Share (Rs.) | 5.68 | 6.04 | 8.09 | 7.59 | 5.24 |
| PBIT / Share (Rs.) | 4.77 | 5.12 | 7.22 | 6.65 | 4.24 |
| PBT / Share (Rs.) | 4.15 | 4.67 | 6.86 | 6.35 | 3.98 |
| Net Profit / Share (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| NP After MI And SOA / Share (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| PBDIT Margin (%) | 15.55 | 17.76 | 21.17 | 20.66 | 16.43 |
| PBIT Margin (%) | 13.06 | 15.08 | 18.87 | 18.10 | 13.30 |
| PBT Margin (%) | 11.35 | 13.73 | 17.95 | 17.27 | 12.48 |
| Net Profit Margin (%) | 8.67 | 10.30 | 13.29 | 13.02 | 9.33 |
| NP After MI And SOA Margin (%) | 8.67 | 10.30 | 13.29 | 13.02 | 9.33 |
| Return on Networth / Equity (%) | 9.52 | 11.34 | 17.98 | 19.75 | 14.59 |
| Return on Capital Employeed (%) | 14.00 | 16.08 | 24.68 | 26.53 | 19.69 |
| Return On Assets (%) | 6.45 | 8.90 | 14.83 | 16.23 | 10.64 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Total Debt / Equity (X) | 0.21 | 0.07 | 0.07 | 0.05 | 0.15 |
| Asset Turnover Ratio (%) | 0.82 | 0.92 | 1.21 | 1.24 | 1.18 |
| Current Ratio (X) | 2.90 | 4.53 | 5.75 | 5.37 | 3.40 |
| Quick Ratio (X) | 1.62 | 2.57 | 2.98 | 2.64 | 1.72 |
| Inventory Turnover Ratio (X) | 2.16 | 0.94 | 1.45 | 1.49 | 1.84 |
| Dividend Payout Ratio (NP) (%) | 25.26 | 25.71 | 19.67 | 16.72 | 21.85 |
| Dividend Payout Ratio (CP) (%) | 19.62 | 20.40 | 16.77 | 13.96 | 16.37 |
| Earning Retention Ratio (%) | 74.74 | 74.29 | 80.33 | 83.28 | 78.15 |
| Cash Earning Retention Ratio (%) | 80.38 | 79.60 | 83.23 | 86.04 | 83.63 |
| Interest Coverage Ratio (X) | 9.11 | 13.20 | 23.02 | 25.04 | 19.89 |
| Interest Coverage Ratio (Post Tax) (X) | 6.08 | 8.65 | 15.46 | 16.78 | 12.30 |
| Enterprise Value (Cr.) | 894.31 | 1285.96 | 1216.71 | 1993.77 | 716.44 |
| EV / Net Operating Revenue (X) | 1.61 | 2.49 | 2.09 | 3.56 | 1.48 |
| EV / EBITDA (X) | 10.34 | 13.99 | 9.87 | 17.24 | 8.99 |
| MarketCap / Net Operating Revenue (X) | 1.48 | 2.47 | 2.07 | 3.55 | 1.41 |
| Retention Ratios (%) | 74.73 | 74.28 | 80.32 | 83.27 | 78.14 |
| Price / BV (X) | 1.62 | 2.72 | 2.80 | 5.39 | 2.21 |
| Price / Net Operating Revenue (X) | 1.48 | 2.47 | 2.07 | 3.55 | 1.41 |
| EarningsYield | 0.05 | 0.04 | 0.06 | 0.03 | 0.06 |
After reviewing the key financial ratios for AVT Natural Products Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.08. This value is within the healthy range. It has decreased from 4.41 (Mar 24) to 4.08, marking a decrease of 0.33.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.25. It has increased from 30.83 (Mar 24) to 33.25, marking an increase of 2.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.25. It has increased from 30.83 (Mar 24) to 33.25, marking an increase of 2.42.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.51. It has increased from 33.97 (Mar 24) to 36.51, marking an increase of 2.54.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.68. This value is within the healthy range. It has decreased from 6.04 (Mar 24) to 5.68, marking a decrease of 0.36.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.77. This value is within the healthy range. It has decreased from 5.12 (Mar 24) to 4.77, marking a decrease of 0.35.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.15. This value is within the healthy range. It has decreased from 4.67 (Mar 24) to 4.15, marking a decrease of 0.52.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.17. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.17. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For PBDIT Margin (%), as of Mar 25, the value is 15.55. This value is within the healthy range. It has decreased from 17.76 (Mar 24) to 15.55, marking a decrease of 2.21.
- For PBIT Margin (%), as of Mar 25, the value is 13.06. This value is within the healthy range. It has decreased from 15.08 (Mar 24) to 13.06, marking a decrease of 2.02.
- For PBT Margin (%), as of Mar 25, the value is 11.35. This value is within the healthy range. It has decreased from 13.73 (Mar 24) to 11.35, marking a decrease of 2.38.
- For Net Profit Margin (%), as of Mar 25, the value is 8.67. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 8.67, marking a decrease of 1.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.67. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 8.67, marking a decrease of 1.63.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.52. This value is below the healthy minimum of 15. It has decreased from 11.34 (Mar 24) to 9.52, marking a decrease of 1.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.00. This value is within the healthy range. It has decreased from 16.08 (Mar 24) to 14.00, marking a decrease of 2.08.
- For Return On Assets (%), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 8.90 (Mar 24) to 6.45, marking a decrease of 2.45.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.21, marking an increase of 0.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.82. It has decreased from 0.92 (Mar 24) to 0.82, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 2.90. This value is within the healthy range. It has decreased from 4.53 (Mar 24) to 2.90, marking a decrease of 1.63.
- For Quick Ratio (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 2.57 (Mar 24) to 1.62, marking a decrease of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 4. It has increased from 0.94 (Mar 24) to 2.16, marking an increase of 1.22.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.26. This value is within the healthy range. It has decreased from 25.71 (Mar 24) to 25.26, marking a decrease of 0.45.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.62. This value is below the healthy minimum of 20. It has decreased from 20.40 (Mar 24) to 19.62, marking a decrease of 0.78.
- For Earning Retention Ratio (%), as of Mar 25, the value is 74.74. This value exceeds the healthy maximum of 70. It has increased from 74.29 (Mar 24) to 74.74, marking an increase of 0.45.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.38. This value exceeds the healthy maximum of 70. It has increased from 79.60 (Mar 24) to 80.38, marking an increase of 0.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.11. This value is within the healthy range. It has decreased from 13.20 (Mar 24) to 9.11, marking a decrease of 4.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.08. This value is within the healthy range. It has decreased from 8.65 (Mar 24) to 6.08, marking a decrease of 2.57.
- For Enterprise Value (Cr.), as of Mar 25, the value is 894.31. It has decreased from 1,285.96 (Mar 24) to 894.31, marking a decrease of 391.65.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 1.61, marking a decrease of 0.88.
- For EV / EBITDA (X), as of Mar 25, the value is 10.34. This value is within the healthy range. It has decreased from 13.99 (Mar 24) to 10.34, marking a decrease of 3.65.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.48, marking a decrease of 0.99.
- For Retention Ratios (%), as of Mar 25, the value is 74.73. This value exceeds the healthy maximum of 70. It has increased from 74.28 (Mar 24) to 74.73, marking an increase of 0.45.
- For Price / BV (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 2.72 (Mar 24) to 1.62, marking a decrease of 1.10.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.48, marking a decrease of 0.99.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AVT Natural Products Ltd:
- Net Profit Margin: 8.67%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14% (Industry Average ROCE: 11.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.52% (Industry Average ROE: 12.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.2 (Industry average Stock P/E: 27.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.21
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.67%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | 60, Rukmani Lakshmipathy Salai, Chennai (Madras) Tamil Nadu 600008 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ajit Thomas | Chairman |
| Mr. A D Bopana | Director |
| Mrs. Shanthi Thomas | Director |
| Mrs. Kavitha Vijay | Director |
| Mr. M M Venkatachalam | Director |
| Mr. Ranganath N Krishna | Director |
| Mr. Rahul Thomas | Director |
FAQ
What is the intrinsic value of AVT Natural Products Ltd?
AVT Natural Products Ltd's intrinsic value (as of 07 January 2026) is ₹44.56 which is 32.07% lower the current market price of ₹65.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹997 Cr. market cap, FY2025-2026 high/low of ₹83.9/51.0, reserves of ₹508 Cr, and liabilities of ₹792 Cr.
What is the Market Cap of AVT Natural Products Ltd?
The Market Cap of AVT Natural Products Ltd is 997 Cr..
What is the current Stock Price of AVT Natural Products Ltd as on 07 January 2026?
The current stock price of AVT Natural Products Ltd as on 07 January 2026 is ₹65.6.
What is the High / Low of AVT Natural Products Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AVT Natural Products Ltd stocks is ₹83.9/51.0.
What is the Stock P/E of AVT Natural Products Ltd?
The Stock P/E of AVT Natural Products Ltd is 16.2.
What is the Book Value of AVT Natural Products Ltd?
The Book Value of AVT Natural Products Ltd is 34.4.
What is the Dividend Yield of AVT Natural Products Ltd?
The Dividend Yield of AVT Natural Products Ltd is 1.07 %.
What is the ROCE of AVT Natural Products Ltd?
The ROCE of AVT Natural Products Ltd is 12.8 %.
What is the ROE of AVT Natural Products Ltd?
The ROE of AVT Natural Products Ltd is 9.89 %.
What is the Face Value of AVT Natural Products Ltd?
The Face Value of AVT Natural Products Ltd is 1.00.